/
/
A study for myeloma patients over 65 wanting an aggressive approach that includes transplant
A study for myeloma patients over 65 wanting an aggressive approach that includes transplant image
A study for myeloma patients over 65 wanting an aggressive approach that includes transplant
Posted Feb 05, 2014

For patients over 65 and in good health, this is a study to determine if a stem cell transplant combined with maintenance therapy is a better option than non-transplant chemotherapy approaches and if it will provide older patients longer remission rates, more time without symptoms, toxicity and therapy, and an improved quality of life. Although several groups have confirmed the feasibility of autologous transplantation in myeloma patients over 65 years of age, the literature related to autotransplantation in this age group remains scarce. Most of the literature related to myeloma treatment in patients over 65 years of age involves non-transplant chemotherapy regimens, so this study will compare the autologous transplant with maintenance therapy compared to non-transplant treatment options for that age group. Study Phase: Phase II Location: University of Iowa For More Information contact Annick Tricot at annick-tricot@uiowa.edu

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

More Life with Myeloma Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811